A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
Open accessPublished version of a preprint
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Nissle 1917 is sold as a probiotic and considered safe even though it has been known since 2006 that it harbors the genes for colibactin synthesis. Colibactin is a potent genotoxin that is now linked to causative mutations found in human colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nissle 1917 contains the pks gene cluster that encodes a series of enzymes that produce a DNA alkylating and double-strand break-inducing genotoxin known as colibactin [23].”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the E. coli strain Nissle 1917, commonly used as a probiotic, also produces colibactin102”
From Human disease models in drug development (2023) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263 · cited 4×
“coli promote colorectal cancer in mouse models (16, 17), and the DNA mutational signature of colibactin has been found in cohorts of patients with colorectal cancer, including in the APC cancer driver gene (9, 11, 18).”
BackgroundInfluentialMechanisms of DNA damage, repair, and mutagenesis
Chatterjee, N., & Walker, G. C. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22087 · Cited by 2,039 · cited 1×
“Mitotic errors can lead to an accumulation of DNA damage, which in turn favors gene mutations (Chatterjee and Walker, 2017; Levine and Holland, 2018).”
BackgroundKruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 1×
“The use of Nissle 1917 is recommended for maintaining remission in ulcerative colitis (2, 3).”
BackgroundMutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H. M., Nomburg, J., Gurjao, C., Manders, F., Dalmasso, G., Stege, P. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2080-8 · Cited by 1,208 · cited 7×
“coli promote colorectal cancer in mouse models (16, 17), and the DNA mutational signature of colibactin has been found in cohorts of patients with colorectal cancer, including in the APC cancer driver gene (9, 11, 18).”
BackgroundInfluentialDNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189 · cited 1×
“plex interplay between DNA repair, cell death, and survival (33).”
BackgroundEscherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188 · cited 1×
“recent biomedical literature, it was shown in 2006 that Nissle 1917 hosts a 54-kb pks island coding for nonribosomal and polyketide synthases (NRPS and PKS, respectively) allowing synthesis of a hybrid peptide-polyketide metabolite called colibactin (5, 6).”
BackgroundSelf-citationPatients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105 · cited 1×
“Inflammation and dysbiosis are also known to allow the expansion of the E. coli population, including that of Nissle 1917, alongside the epithelium (Cevallos et al., 2019; Dejea et al., 2018; Zhu et al., 2019).”
BackgroundEscherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells
Cuevas-Ramos, G., Petit, C. R., Marcq, I., Boury, M., Oswald, E., & Nougayrède, J.-P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001261107 · Cited by 855 · cited 17×
“Infection with a MOI of 20 Nissle 1917 resulted in a significant increase of hprt mutation frequency.”
BackgroundResultSelf-citationThe landscape of somatic mutation in normal colorectal epithelial cells
Lee-Six, H., Olafsson, S., Ellis, P., Osborne, R. J., Sanders, M. A., Moore, L., Georgakopoulos, N., Torrente, F., Noorani, A., Goddard, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1672-7 · Cited by 747 · cited 2×
“…et al., 2020; Pleguezuelos-Manzano et al., 2020; Terlouw et al., 2020) and also in colonic crypts from healthy individuals under the age of ten (Lee-Six et al., 2019) proves that colibactin is expressed within the human gut (including in child), and links colibactin exposure to colorectal…”
BackgroundThe Human Gut Bacterial Genotoxin Colibactin Alkylates DNA
Wilson, M. R., Jiang, Y., Villalta, P. W., Stornetta, A., Boudreau, P. D., Carrá, A., Brennan, C. A., Chun, E., Ngo, L., Samson, L. D., et al. (2019) · Science · doi:10.1126/science.aar7785 · Cited by 635 · cited 5×
“(19) were inappropriate, in contrast to the assays used in the present and other works (12, 32), to highlight the DNA-damaging activity and genotoxicity of”
BackgroundMethodResultInfluential
Cited by
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Bell, H. N., Rebernick, R. J., Goyert, J., Singhal, R., Kuljanin, M., Kerk, S. A., Huang, W., Das, N. K., Andren, A., Solanki, S., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.001 · Cited by 296
“Recent studies have advanced insights into the mechanisms by which pathogenic bacteria promote tumor growth and survival, such as by inducing inflammation, generating biofilms, and secreting genotoxins (Dejea et al., 2018, Pleguezuelos-Manzano et al., 2020; Tomkovich et al., 2019; Nougayrede et al., 2021).”
BackgroundEmerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230
Clean-label alternatives for food preservation: An emerging trend
Chauhan, K., & Rao, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35815 · Cited by 177
Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Bae, S., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Kansra, V. V., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.007 · Cited by 139
Rosendahl Huber, A., Pleguezuelos-Manzano, C., Puschhof, J., Ubels, J., Boot, C., Saftien, A., Verheul, M., Trabut, L. T., Groenen, N., van Roosmalen, M., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.02.009 · Cited by 106
Probiotics, Their Extracellular Vesicles and Infectious Diseases
Rubio, A. P. D., D’Antoni, C. L., Piuri, M., & Pérez, O. E. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.864720 · Cited by 98
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases
Shen, H., Zhao, Z., Zhao, Z., Chen, Y., & Zhang, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020594 · Cited by 58
“However, 1917 can also produce colibactin in vitro and in vivo, inducing DNA damage, which may contribute to the development of colorectal cancer [48].”
BackgroundEscherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
Liu, Q., Gai, Y., Chen, Y., Lan, X., & Jiang, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081226 · Cited by 50
“for colibactin, which may induce mutagenic DNA damage [64].”
BackgroundMicrocins reveal natural mechanisms of bacterial manipulation to inform therapeutic development
Parker, J. K., & Davies, B. W. (2022) · Microbiology · doi:10.1099/mic.0.001175 · Cited by 55
“coli Nissle, for example, has recently been suggested to have genotoxic and mutagenic activity [233].”
BackgroundEffendi, S. S. W., & Ng, I. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2109405 · Cited by 49
“Considering such characteristics, BGs are recognized as safe approaches to avoiding the questionable risk of colibactin (Liu et al. 2021), which may induce mutagenic DNA damage (Nougayr ede et al. 2021).”
BackgroundGastrointestinal Biofilms: Endoscopic Detection, Disease Relevance, and Therapeutic Strategies
Jandl, B., Dighe, S. N., Baumgartner, M., Makristathis, A., Gasché, C., & Muttenthaler, M. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.04.032 · Cited by 57
Lerner, A., Benzvi, C., & Vojdani, A. (2024) · Microorganisms · doi:10.3390/microorganisms12020238 · Cited by 53
“One recent example is the engineered E. coli Nissle 1917 involvement in colorectal cancer [102].”
BackgroundMutators can drive the evolution of multi-resistance to antibiotics
Gifford, D. R., Berríos-Caro, E., Joerres, C., Suñé, M., Forsyth, J. H., Bhattacharyya, A., Galla, T., & Cg, K. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010791 · Cited by 48
A CRISPR-Cas9 system protecting E. coli against acquisition of antibiotic resistance genes
Lee, D., Muir, P., Lundberg, S., Lundholm, A., Sandegren, L., & Koskiniemi, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-85334-2 · Cited by 45
Weibel, N., Curcio, M., Schreiber, A., Arriaga, G., Mausy, M., Mehdy, J., Brüllmann, L., Meyer, A., Roth, L., Flury, T., et al. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00036 · Cited by 41
“Additionally, the interactions between the host immune system and engineered probiotics require thorough investigation to ensure long-563 term efficacy and safety 95,96 .”
BackgroundFalzone, L., Lavoro, A., Candido, S., Salmeri, M., Zanghì, A., & Libra, M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2397874 · Cited by 35
“28 In 2020, another study explored the pathogenic potential of EcN compared to enterohe-morrhagic (EHEC) and uropathogenic (UPEC) Escherichia coli strains.”
BackgroundResultDesigning live bacterial therapeutics for cancer
Lee, J., McClure, S., Weichselbaum, R. R., & Mimee, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115579 · Cited by 35
Xu, R., Yu, Y., & Chen, T. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101044 · Cited by 31
“Nougayr ` ede et al. report that Escherichia. coli Nissil ¨ a et al., 2017, a widely used probiotic strain, possesses colibactin synthesis genes (Nougayr ` ede et al., 2021).”
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. Ø., & Sommer, M. O. A. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-05108-9 · Cited by 29
“The pks island is associated with EcN’s probiotic effect, but its product, the genotoxin colibactin, has been linked to colorectal cancer [14, 15, 16, 17].”
BackgroundInfluentialDelivery, structure, and function of bacterial genotoxins
Du, L., & Song, J. (2022) · Virulence · doi:10.1080/21505594.2022.2097417 · Cited by 30
Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review
Gopalan, S., Ganapathy, S., Mitra, M., ., N., Joshi, D. K., Veligandla, K. C., Rathod, R., & Kotak, B. P. (2023) · Cureus · doi:10.7759/cureus.46314 · Cited by 50
“This is a serious safety concern that should not be ignored keeping in mind the health of patients and the general public overall [39].”
BackgroundLi, S., & Zhang, Y.-X. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2202237 · Cited by 26
“From the considerable clinical efficacy available, no good new commercial E. coli strain is available that can take the place of Nissle 1917 due to its ecological niche in the lower gut (Soundararajan et al. 2019; Nougayrede et al. 2021; Effendi and Ng 2022).”
BackgroundMäklin, T., Taira, A., Arredondo-Alonso, S., Shao, Y., Stratton, M. R., Lawley, T. D., Aaltonen, L. A., & Corander, J. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.101015 · Cited by 22
Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster
Kalantari, A., James, M. J., Renaud, L., Perreault, M., Monahan, C. E., McDonald, M. N., Hava, D. L., & Isabella, V. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280499 · Cited by 26
Fu, Y., Gao, H., Hou, X., Chen, Y., & Xu, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1014881 · Cited by 24
Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in ApcMin/+ mice
Oliero, M., Hajjar, R., Cuisiniere, T., Fragoso, G., Calvé, A., & Santos, M. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1067505 · Cited by 19
“Since EcN has been identified as potentially harmful for the host due to the presence of colibactin genes (Nougayrède et al., 2021), its pasteurization would have the advantage of resulting into colibactin degradation due to its high instability (Dougherty and Jobin, 2021).”
BackgroundOxygen concentration modulates colibactin production
Bossuet‐Greif, N., Guyonnet, C., Chagneau, C. V., Tang-Fichaux, M., Pénary, M., Loubet, D., Branchu, P., Oswald, É., & Nougayrède, J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2222437 · Cited by 23
“coli pks+ (NC101, 192PP, M1/5, SP15, 11G5, the probiotic strain 248 Nissle 1917) (15, 17, 19, 20, 46, 47).”
Self-citationEvaluation of Human Performance Aiding Live Synthetically Engineered Bacteria in a Gut-on-a-Chip
Nelson, M., Coia, H. G., Holt, C., Greenwood, E. S., Narayanan, L., Robinson, P. J., Merrill, E. A., Litteral, V., Goodson, M. S., Saldanha, R., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00774 · Cited by 19
Sogari, A., Rovera, E., Grasso, G., Mariella, E., Reilly, N. M., Lamba, S., Mauri, G., Durinikova, E., Vitiello, P. P., Lorenzato, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101376 · Cited by 17
“25,26 RS results from a variety of endogenous and exogenous genotoxic stressors that hamper or perturb DNA replication, leading to accumulation of single-strand breaks (SSBs) and DSBs. 27 Cells activate an intricate network of DNA damage response and repair (DDR) pathways to resolve damage and…”
Wang, Y., Xiao, S., Yu, W., Han, B. R., & Guo, G. F. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01766-3 · Cited by 26
“…infiltration remain unclear, studies have demonstrated that Gram-negative species such as Salmonella typhimurium [42] and non-pathogenic Escherichia coli [43–45], as well as Gram-positive species such as Clostridium butyricum [46] and Listeria monocytogenes [47], preferentially colonize tumors.”
Establishing Heterologous Production of Microcins J25 and Y in Bacillus subtilis
Zhang, G., Lin, M., Qin, M., Xie, Q., Liang, M., Jiang, J., Dai, H., Xu, S., Feng, S., & Liao, M. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00675 · Cited by 17
Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Yang, M., Zhong, P., & Wei, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052056 · Cited by 18
“By inhibiting colibactin synthesis, this modification minimizes the risk of such DNA damage, enhancing the safety profile of EcN as a therapeutic vehicle [134].”
D-Serine reduces the expression of the cytopathic genotoxin colibactin
Hallam, J. C., Sandalli, S., Floria, I., Turner, N. C. A., Tang-Fichaux, M., Oswald, É., O’Boyle, N., & Roe, A. J. (2023) · Microbial Cell · doi:10.15698/mic2023.03.793 · Cited by 18
Escherichia coli on colorectal cancer: A two‐edged sword
Chu, J., Wu, Y., Jing, Z., Zhanbo, Q., Zefeng, W., & Han, S. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.70029 · Cited by 22
“The relationship between the pathogenicity of the pks island and the probiotic activity of EcN is closer than expected, which indicates the co-evolution of these factors to adapt to diverse environments (Lynch et al., 2022; Massip et al., 2019; Nougayrède et al., 2021; Rehm et al., 2021).”
BackgroundGenetic heterogeneity of engineered Escherichia coli Nissle 1917 strains during scale-up simulation
Munkler, L. P., Mohamed, E. T., Vazquez-Uribe, R., Nissen, V. V., Rugbjerg, P., Worberg, A., Woodley, J. M., Feist, A. M., & Sommer, M. O. A. (2024) · Metabolic Engineering · doi:10.1016/j.ymben.2024.08.001 · Cited by 18
Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917
Radford, G., Vrbanac, L., de Nys, R., Worthley, D. L., Wright, J. A., Hasty, J., & Woods, S. L. (2024) · Cancers · doi:10.3390/cancers16172971 · Cited by 20
“Oral dosing of germ-free mice with wild-type pks + EcN also caused DNA damage to epithelial cells lining the gut in vivo [62], and recently, the colibactin mutational DNA signature has been identified in approximately 12% of human colorectal cancer samples [60].”
BackgroundKaymak‐Ertekin, F., Aydın, Ö. K., & Altay, Ö. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4572 · Cited by 14
Chamas, A., Svensson, C., Maneira, C., Sporniak, M., Figge, M. T., & Lackner, G. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00466 · Cited by 15
Mirsepasi‐Lauridsen, H. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247472 · Cited by 18
“coli Nissle 1917, from the B2 phylogenetic group [47], harbors genes for colibactin synthesis inducing DNA damage which is linked to colorectal cancer [64].”
BackgroundExpectations for employing Escherichia coli Nissle 1917 in food science and nutrition
Hu, M., Zhang, T., Miao, M., Li, K., Luan, Q., & Sun, G. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2301416 · Cited by 14
Markelova, N. N., Semenova, E. F., Синева, О. Н., & Sadykova, V. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911706 · Cited by 12
Cabral, V., Oliveira, R. A., Correia, M. B., Pedro, M. F., Garcia‐Garcerà, M., Úbeda, C., & Xavier, K. B. (2025) · Nature Communications · doi:10.1038/s41467-025-67015-w · Cited by 10
“Notably, ARO112 demonstrated to have a lower pathogenic potential in comparison with the clinical isolate Kp1012, and similar or lower than our control probiotic strain, EcN, which has previously been reported 35,36 to expresses several traits that are commonly associated with pathogenesis.”
Recent advances in the use of bacterial probiotics in animal production
Evangelista, A. G., Corrêa, J. A. F., Pinto, A. C. S. M., Gonçalves, F. D. R., & Luciano, F. B. (2023) · Animal Health Research Reviews · doi:10.1017/s1466252323000063 · Cited by 9
“Although E. coli strains considered safe have been used as probiotics for decades, recent research indicates that their use may pose risks to the consumer (Massip et al ., 2019; Nougayrède et al ., 2021).”
Pierro, F. D., Thacharodi, A., Kumaraswami, M., Suvorov, A. N., Zupet, J., & Zerbinati, N. (2026) · Microbial Cell Factories · doi:10.1186/s12934-026-02997-w · Cited by 12
“The probiotic E. coli strain known as Nissle 1917 also contains the pks gene cluster and secretes colibactin [45].”
Dubbert, S., & von Bünau, R. (2021) · mSphere · doi:10.1128/msphere.00856-21 · Cited by 6
“We read with interest the publication by Nougayrède and coworkers who described that Escherichia coli strain Nissle 1917 (EcN) is mutagenic by means of its expressed colibactin (1).”
BackgroundMethodResultInfluentialHe, X., Ren, E., Dong, L., Yuan, P., Zhu, J., Liu, D., & Wang, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37346 · Cited by 8
“Tumor cell-released exosomes are known to have distinct RNA and protein contents, and they are being recognized as a key player in the communication network that facilitates the growth of tumors [22].”
BackgroundTasnim, F., Hosen, M. E., Haque, M. E., Islam, A., Nuryay, M. N., Mawya, J., Akter, N., Yesmin, D., Hossain, M. M., Rahman, N., et al. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00276-3 · Cited by 6
“E. coli is usually harmless in the intestinal lumen (Nougayrède et al. 2021 ) but can cause infections in immunocompromised individuals or those with compromised GIT barriers (Pokharel et al. 2023 ).”
Mutators drive evolution of multi-resistance to antibioticsPreprint
Gifford, D. R., Berríos-Caro, E., Joerres, C., Suñé, M., Forsyth, J. H., Bhattacharyya, A., Galla, T., & Cg, K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/643585 · Cited by 6
Quantifying Metagenomic Strain Associations from Microbiomes with AnpanPreprint
Ghazi, A. R., Thompson, K. N., Bhosle, A., Mei, Z., Yan, Y., Wang, F., Wang, K., Franzosa, E. A., & Huttenhower, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.06.631550 · Cited by 11
Di Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10522-5 · Cited by 5
“…with their efficacy; (iii) be involved in the production and metabolism of histamine (potentially promoting intestinal inflammatory response); or (iv) be associated with the transmission of antibiotic resistance elements or with the production of genotoxic metabolites, such as colibactin [16–23].”
Hemati, S., Abdolalipour, E., Emadi, A., Ghadiri-Asli, S.-A., Aghababa, A. A., Sanami, S., Naderian, R., Mahooti, M., & Zare, D. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107400 · Cited by 5
Dougherty, M. W., Hoffmann, R. M., Hernandez, M. C., Airan, Y., Gharaibeh, R. Z., Herzon, S. B., Yang, Y., & Jobin, C. (2025) · mSphere · doi:10.1128/msphere.00692-24 · Cited by 6
“…gap in knowledge that may partially explain why approximately 20% of healthy people can be colonized by pks + E. coli (2) without tumor formation, or the presence of the pks gene island in the common probiotic E. coli strain Nissile 1917 (10) without documented carcinogenic consequences.”
Vajagathali, M., Hannah, E., Abirami, K., Tharanya, M., Jackson, J. G., Karthik, R., Aaron, S., & Meenakshi, S. (2017) · Beneficial Microbes · doi:10.1163/18762891-20230001 · Cited by 4
García, M., Ruiz, M. J., Medina, L. M., Vidal, R. M., Padola, N. L., & Etcheverría, A. I. (2023) · Foods · doi:10.3390/foods12142676 · Cited by 5
Uchiyama, H., Kudo, T., Yamaguchi, T., Obana, N., Watanabe, K., Abe, K., Miyazaki, H., Toyofuku, M., Nomura, N., Akeda, Y., et al. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2337987 · Cited by 4
“17,18 A more recent investigation confirmed genotoxic and mutagenic activities in EcN, 19 suggesting the potential for adverse events, such as inflammation and carcinogenesis.”
Jans, M., Kolata, M., Blancke, G., Ciers, M., Dohlman, A. B., Kusakabe, T., Sze, M., Thiran, A., Berx, G., Tejpar, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553526 · Cited by 4
Chemiluminescent Probes Allow for the Rapid Identification of Colibactin-Producing Bacteria
Ramos, M. A. A., Gutkin, S., David, M., Shabat, D., & Balskus, E. P. (2026) · JACS Au · doi:10.1021/jacsau.6c00004 · Cited by 3
Menta, L. N. K., Law, S. K. K., & Tan, H. S. (2024) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2024.2353736 · Cited by 3
“Hence, introducing EcN1917 into the larval hemolymph via injection may cause both bacteraemia and septicaemia, contributing to larval mortality at higher concentrations (Nougayrède et al. 2021; Lynch et al. 2022).”
Reply to Dubbert and von Bünau, “A Probiotic Friend”
Nougayrède, J., & Oswald, É. (2021) · mSphere · doi:10.1128/msphere.00906-21 · Cited by 13
“We read with great interest the comment letter to the editor by Dubbert and von Bünau (1) from Ardeypharm regarding our work, recently published in mSphere, on the production of the genotoxin colibactin by the Nissle 1917 probiotic (2).”
BackgroundResultSelf-citationSticky situation: how adhesive bacteria drive colon cancer
Ouyang, K. S., & Puschhof, J. (2024) · Nature · doi:10.1038/d41586-024-03285-6 · Cited by 2
Host interactions of bioactive molecules produced by Klebsiella spp
McCartney, A. L., & Hoyles, L. (2025) · Microbiota and Host · doi:10.1530/mah-24-0011 · Cited by 6
Barrack, K. E., Surve, S. V., Bezerra, A. K. S., Murphy, C. E., Soucy, S. M., Ramos, M. A. A., Valls, R. A., Ruff, R. D., Balskus, E. P., Sanville, J. L., et al. (2026) · Journal of Bacteriology · doi:10.1128/jb.00190-26 · Cited by 3
“This phenomenon has been explored in numerous studies which generally support the use of Nissle as a probiotic strain, despite its pks + status (65, 66).”
Zhu, Q., Feng, S., Yan, Z., Wang, Z., Huang, X., Sun, C., Zhang, B., Li, X., & Gu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1865862 · Cited by 3
“It has been used clinically for over a century (e.g., in Muta fl or ® ) (20, 21), is endorsed by European Crohn ’ s and Colitis Organisation (ECCO) guidelines for UC maintenance therapy (22, 23), and exhibits superior gut-colonizing capacity (24) compared to transient colonizers like Lactococcus…”
Fermented foods, prebiotics, and probiotics
Diez‐Echave, P., Hidalgo‐Garcia, L., Molina‐Tijeras, J. A., Algieri, F., Rodríguez‐Cabezas, M. E., Rodríguez‐Nogales, A., & Gálvez, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99111-7.00012-x · Cited by 2
Engineered E. coli for the targeted deposition of therapeutic payloads to sites of diseasePreprint
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Glickman, J. N., Leong, J. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1233122/v1 · Cited by 2
Microbial medics diagnose and treat gut inflammation
Tanna, T., & Platt, R. J. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.01.012 · Cited by 2
Jousserand, N., Massiera, B., Bordignon, P., Boury, M., Tremblay‐Franco, M., Dobrindt, U., Martín, P., Lavoué, R., Oswald, É., & Payros, D. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10777-y · Cited by 1
“Thus, the safety of EcN needs to be discussed [29].”
The therapeutic potential of D-Serine in reducing expression of the cytopathic genotoxin colibactinPreprint
Hallam, J. C., O’Boyle, N., Turner, N. C. A., Tang-Fichaux, M., Oswald, É., & Roe, A. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.08.483572 · Cited by 1
Azour, A., Al-Bayssari, C., & Rolain, J. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4863297 · Cited by 1
Rehabilitation of the ‘bad guys’ for biocontrol applications
Eberl, L. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.16216
clbP Gene, a Potential New Member of the β-Lactamase Family
Azour, A., Al-Bayssari, C., Pinault, L., Azza, S., Rolain, J., & Diene, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415642
“coli stra ns that contain this gene cluster cause DNA double-strand breaks in human eukaryotic cells [12,22].”
BackgroundNon-lactic Acid Bacteria and Other Novel Probiotics
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65455-8_7
Kamel, A. A., & Mahmood, S. S. (2025) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2025.033.2.01
Marquant, Q., Chottin, C., Ferret, C., Poucet, E., Saint‐Criq, V., Laubreton, D., Drajac, C., Bouguyon, E., Rémot, A., Constant, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.05.692516
Self-citationChen, X., Peng, Y., Zhang, Y., Li, X., Wu, W., Li, Y., & 黄莉萍 (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176347
Karaman, T., Mansur, N., Tiftikçi, A., Yapalı, S., Aygün, C., Sezerman, O. U., Kocagöz, T., Tozun, N., & Okullu, S. Ö. (2026) · AMB Express · doi:10.1186/s13568-026-02084-8
“One isolate was identified as Escherichia coli Nissle 1917 (EcN), a widely used probiotic strain that nonetheless harbors the pks genomic island responsible for colibactin biosynthesis (Nougayrède and Chagneau 2021; Falzone et al. 2024).”
He, Y., 李廷慧, Sun, H., & Yang, J. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05023-0
“Therefore, EcN should be interpreted in a context-dependent manner rather than simply classified as benefi - cial or harmful (Massip et al. 2019; Nougayrede et al. 2021; Rosendahl Huber et al. 2024).”
Chen, W.-M., Sun, M.-Y., Ye, J., Tan, D.-C., Zhang, Z.-Y., & Liu, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1812973
Deeb, N., Otinov, G. D., & Koshel, E. I. (2026) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162026602120
Liao, J., Zhou, M.-L., Lin, D.-Y., Zalán, Z., & Suo, H. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110069
Engineering electrospun living nanofibers for oral therapeutics
Ferrace, M. N., Ballarin, F. M., Rivero, G., Bruyère, J., Cabral, H., Cattoni, D. I., & Abraham, G. A. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116263
Metadata
- Authors
- Nougayrède, J.-P., Chagneau, C. V., Motta, J.-P., Bossuet-Greif, N., Belloy, M., Taieb, F., Gratadoux, J.-J., Thomas, M., Langella, P., & Oswald, E.
- Affiliations
- Inserm (FR)
- IRSD, INSERM, INRAE, Université de Toulouse, ENVT, Toulouse, France
- Microbiologie de l’alimentation au service de la santé (FR)
- Corresponding author
- Nougayrède, Jean-Philippe
- ORCID
- Venue
- mSphere
- Publisher
- American Society for Microbiology
- Published
- 2021-08-25
- Volume
- 6
- Issue
- 4
- Pages
- e0062421-e0062421
- ISSN
- 2379-5042 (ISSN-L)
- PMC
- PMC8386472
- OpenAlex
- W3190012438
- Cited by
- 82
- References
- 54
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 21 · 2023: 15 · 2022: 15 · 2021: 4
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSphere (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Institut National Du Cancer (PLBIO13-123)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- Escherichia coli Nissle 1917, probiotics, colibactin, genotoxicity, mutagenicity, colorectal cancer, bacterial genotoxins, probiotic safety
- MeSH terms
- Animals, Cricetulus, DNA Damage, Epithelial Cells, Escherichia coli, Escherichia coli Infections, Female, HeLa Cells, Humans, Mutation, Mutagenesis, CHO Cells, Genome, Bacterial, Probiotics, Escherichia coli Proteins, Genomic Islands, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.